Business Context and Reporting Period
This Form 8-K, dated December 18, 2013, reports the completion of a transformative transaction for Perrigo Company plc ("New Perrigo"). On this date, New Perrigo acquired Elan Corporation, plc ("Elan") and merged with its former parent, Perrigo Company. Following the transaction, both Perrigo and Elan became wholly-owned subsidiaries of New Perrigo. The new entity's ordinary shares began trading on the NYSE and Tel Aviv Stock Exchange under the symbol "PRGO."
Key Financial Metrics and Capital Structure
The filing details significant debt financing and equity restructuring but does not provide operational financial metrics such as revenue, profit, or cash flow for the period.
- Debt Issuance: In November 2013, the Issuer raised $2.3 billion in aggregate principal amount of Senior Notes:
- $500 million of 1.30% Senior Notes due 2016
- $600 million of 2.30% Senior Notes due 2018
- $800 million of 4.00% Senior Notes due 2023
- $400 million of 5.30% Senior Notes due 2043
- Debt Termination: The 2011 Credit Agreement was terminated in its entirety effective December 18, 2013.
- Equity Consideration:
- Elan shareholders received $6.25 in cash and 0.07636 of a New Perrigo ordinary share per Elan share/ADS.
- Perrigo shareholders received $0.01 in cash and one New Perrigo ordinary share per Perrigo common share.
Material Changes Versus Prior Period
The primary material change is the corporate restructuring resulting in a new parent entity, New Perrigo. Key changes include:
- Corporate Structure: Transition from separate Perrigo and Elan entities to a single holding company structure with both as subsidiaries.
- Securities Listing: Perrigo Common Shares and Elan ADSs were suspended from trading and will be delisted. New Perrigo Ordinary Shares are now the registered securities.
- Legal Agreements: Execution of supplemental indentures making Perrigo and subsidiaries guarantors of the Notes, and entry into new indemnification agreements for directors and officers under Irish and Michigan law.
Guidance, Outlook, Risks, and Unusual Items
The filing contains no specific financial guidance or revenue outlook. It includes a standard forward-looking statement disclaimer regarding risks that could cause actual results to differ from expectations.
- Key Risks Identified:
- Successful integration of the Elan acquisition and realization of synergies.
- Uncertainty regarding pending or future litigation and government investigations.
- Patent infringement litigation outcomes and potential settlements.
- Foreign currency exchange rate fluctuations.
- Regulatory changes affecting pricing and reimbursement (e.g., Medicare, Medicaid).
- Product liability claims and manufacturing delays.
- Unusual Items: The filing notes that pro forma financial information and financial statements of the business acquired are to be filed by amendment within 71 calendar days; they are not included in this report.
Investor Verification Checklist
- Verify the final trading status and ticker symbol (PRGO) on the NYSE and TASE.
- Review the upcoming pro forma financial information (due within 71 days) to assess the combined entity's financial position.
- Confirm the terms of the new Senior Notes and the full termination of the 2011 Credit Agreement.
- Monitor the integration progress of Elan and the realization of anticipated synergies.
- Review the status of any pending litigation or regulatory investigations mentioned in the risk factors.